# Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)

> **NCT01721291** · PHASE4 · COMPLETED · sponsor: **Imperial College London** · enrollment: 65 (actual)

## Conditions studied

- CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- ASTHMA
- HEALTHY SUBJECTS

## Interventions

- **DRUG:** SALBUTAMOL

## Key facts

- **NCT ID:** NCT01721291
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-01
- **Primary completion:** 2017-11-27
- **Final completion:** 2017-11-27
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2023-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01721291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01721291, "Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT01721291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*